Projects per year
Fingerprint
Dive into the research topics where Shannon McWeeney is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pacific NorthWest Regional Center of Excellence (PNWRCE)
Axthelm, M., Barklis, E., Frueh, K., McWeeney, S., Moses, A., Nelson, J., Slifka, M. & Streblow, D.
Project: Research project
-
Behavioral Genomics of Alcohol Neuroadaptation
Buck, K., Conrad, D., Ford, M., Grant, K., Guizzetti, M., Hitzemann, R., McWeeney, S., Nagel, B., Ryabinin, A., Belknap, J., Crabbe, J. J., Mitchell, S. & Phillips, T.
Project: Research project
-
Illuminating molecular targetable pathways in HNSCC
Kulesz-Martin, M. & McWeeney, S.
Project: Research project
-
-
-
A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
Damnernsawad, A., Bottomly, D., Kurtz, S. E., Eide, C. A., McWeeney, S. K., Tyner, J. W. & Nechiporuk, T., Jan 2022, In: Haematologica. 107, 1, p. 77-85 9 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
Kurtz, S., Eide, C. A., Kaempf, A., Long, N., Bottomly, D., Nikolova, O., Druker, B. J., McWeeney, S. K., Chang, B. H., Tyner, J. W. & Agarwal, A., May 24 2022, In: Blood Advances. 6, 10, p. 3062-3067 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia (Nature Communications, (2019), 10, 1, (5455), 10.1038/s41467-019-13364-2)
Braun, T. P., Okhovat, M., Coblentz, C., Carratt, S. A., Foley, A., Schonrock, Z., Curtiss, B. M., Nevonen, K., Davis, B., Garcia, B., LaTocha, D., Weeder, B. R., Grzadkowski, M. R., Estabrook, J. C., Manning, H. G., Watanabe-Smith, K., Jeng, S., Smith, J. L., Leonti, A. R., Ries, R. E., & 8 others, Dec 2022, In: Nature communications. 13, 1, 3471.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma
Thieme, E., Liu, T., Bruss, N., Roleder, C., Lam, V., Wang, X., Nechiporuk, T., Shouse, G., Danilova, O. V., Bottomly, D., McWeeney, S. K., Tyner, J. W., Kurtz, S. E. & Danilov, A. V., Mar 2022, In: Cell Death and Disease. 13, 3, 246.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib
Vigoda, M., Mathieson, C., Evans, N., Hale, C., Jennings, J., Lucero, O., Jeng, S., Bottomly, D., Clayburgh, D., Andersen, P., Li, R., Petrisor, D., Tyner, J. W., McWeeney, S. & Kulesz-Martin, M., 2022, In: Cancer Biology and Therapy. 23, 1, p. 310-318 9 p.Research output: Contribution to journal › Article › peer-review
Open Access